FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that process about 80% of prescriptions in the United States — Caremark,
FTC Sues Top Pharmacy Benefit Managers Over Insulin Prices
Some of the PBMs named by the FTC said in statements that the government's action showed that it does not understand how drug pricing works. But the FTC said the current system pr
FTC lawsuit claims drug middlemen are manipulating insulin market
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that spur price increases, the
High insulin prices spur lawsuit against 3 pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers, or PBMs, over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that process about 80% of prescriptions in the United States - Caremark,
FTC sues pharmacy insurance managers, alleging unfair drug prices
The FTC accuses the largest pharmacy benefit manager companies of unfairly boosting prices on prescription drugs.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
Wall Street Journal8mon
Reporter, The Wall Street Journal
Anna Wilde Mathews covers health insurance for the Wall ... pharmacy-benefit managers, hospitals, the Food and Drug Administration, and health policy in Washington. She was part of a team of ...
Cigna Demands FTC Retraction in Escalating Drug-Price Fight
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...
Pharmacy benefit managers shouldn’t have free rein to drive up drug prices
Called pharmacy benefit managers ... and payers and to steer patients toward more expensive drugs. The Wall Street ...
wbng1d
FTC sues over allegedly inflated insulin prices
(AP) - The federal government is suing some big pharmacy benefit managers over a system of drug rebates ... would seek ...
Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says
The FTC, in a report released Tuesday, detailed a number of actions that it said large pharmacy-benefit managers ...
kffhealthnews3d
From KFF Health News - Latest Stories:
The New York Times: Deep Links Between Alcohol And Cancer Are Described In New Report Adults under age 50 have been developing breast cancer and colorectal cancer at increasingly higher rates ...
Express Scripts sues FTC over report blasting pharmacy middlemen
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and ...